提供を拡大するための黄熱ワクチンの分量投与:モデリング研究
Joseph T Wu1, Corey M Peak2, Gabriel M Leung1
1WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Lancet (London, England)
|November 14, 2016
まとめ
分量黄熱ワクチンは,効果が予想より低い場合でも,感染率を大幅に低下させることができます. この投与量削減戦略は 疫病の管理と疫病発生時のワクチン供給の維持に 有効なアプローチを提供する.
科学分野:
- 流行病学
- 感染症
- ワクチン学
背景:
- アンゴラの黄熱病は 世界的なワクチンの供給を圧迫した.
- WHOは金シャサで5倍分量黄熱ワクチンを使用した (2016).
- 分量ワクチンの有効性については,さらなる調査が必要である.
研究 の 目的:
- アンゴラにおける黄熱の生殖率を推定する.
- 分量ワクチン接種で黄熱の伝播動態をモデル化する.
- 伝播を減らすために有効な用量分割の条件を決定する.
主な方法:
- アンゴラの自然病歴と症例データを活用した.
- 感染率と感染率をシミュレートするために数学的モデルを使用した.
- 分量ワクチンの効能と年齢の切り離しの影響の評価
主要な成果:
- アンゴラの実際の生殖数は5.2から7.1と推定されている.
- 分量ワクチン接種は,有効性 > 1/ n の場合,感染発症率を著しく低下させる.
- キンシャサでのWHOの2年間の年齢制限は,5倍分量投与の有効性が20%を超えると有効です.
結論:
- 黄熱の感染率を減らすための強力な戦略です.
- このアプローチは,予想より低いワクチンの有効性に対する安全性範囲を提供します.
- 分量ワクチン接種は疫病の際の有効な公衆衛生対策です
関連する概念動画
Dosage Regimens: Partial Pharmacokinetic Parameters
245
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
245
Dosage Interval and Administration Route: Determination Methods
389
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
389
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
328
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
328
Dose Size and Dosing Frequency: Determination Methods
466
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
466
Vaccinations
53.1K
Overview
53.1K
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
324
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
324


